These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 29285833)

  • 1. Regulatory mechanisms of hypoxia-inducible factor 1 activity: Two decades of knowledge.
    Koyasu S; Kobayashi M; Goto Y; Hiraoka M; Harada H
    Cancer Sci; 2018 Mar; 109(3):560-571. PubMed ID: 29285833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATR controls cellular adaptation to hypoxia through positive regulation of hypoxia-inducible factor 1 (HIF-1) expression.
    Fallone F; Britton S; Nieto L; Salles B; Muller C
    Oncogene; 2013 Sep; 32(37):4387-96. PubMed ID: 23085754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIF pathway: implications for patterns of gene expression in cancer.
    Wykoff CC; Pugh CW; Harris AL; Maxwell PH; Ratcliffe PJ
    Novartis Found Symp; 2001; 240():212-25; discussion 225-31. PubMed ID: 11727931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDX5 enhances HIF-1 activity by promoting the interaction of HIF-1α with HIF-1β and recruiting the resulting heterodimer to its target gene loci.
    Shirai Y; Suwa T; Kobayashi M; Koyasu S; Harada H
    Biol Cell; 2024 Feb; 116(2):e2300077. PubMed ID: 38031929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor-1 (HIF-1).
    Ke Q; Costa M
    Mol Pharmacol; 2006 Nov; 70(5):1469-80. PubMed ID: 16887934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
    Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
    Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive HIF-1 activity in malignant melanoma.
    Kuphal S; Winklmeier A; Warnecke C; Bosserhoff AK
    Eur J Cancer; 2010 Apr; 46(6):1159-69. PubMed ID: 20185296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms.
    Zhong H; Willard M; Simons J
    Int J Cancer; 2004 Nov; 112(4):585-95. PubMed ID: 15382039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
    Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
    Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Regulatory Mechanism of Hypoxia-inducible Factor 1 and its Clinical Significance.
    Yin CL; Ma YJ
    Curr Mol Pharmacol; 2024; 17():e18761429266116. PubMed ID: 38389420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Casein kinase 1 regulates human hypoxia-inducible factor HIF-1.
    Kalousi A; Mylonis I; Politou AS; Chachami G; Paraskeva E; Simos G
    J Cell Sci; 2010 Sep; 123(Pt 17):2976-86. PubMed ID: 20699359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confluence-dependent resistance to doxorubicin in human MDA-MB-231 breast carcinoma cells requires hypoxia-inducible factor-1 activity.
    Fang Y; Sullivan R; Graham CH
    Exp Cell Res; 2007 Mar; 313(5):867-77. PubMed ID: 17289019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer therapeutic agents targeting hypoxia-inducible factor-1.
    Wang R; Zhou S; Li S
    Curr Med Chem; 2011; 18(21):3168-89. PubMed ID: 21671859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
    Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
    Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel induced-JNK2/PHD1 signaling pathway increases degradation of HIF-1α and causes cancer cell death under hypoxia.
    Oh ET; Kim CW; Kim SJ; Lee JS; Hong SS; Park HJ
    Sci Rep; 2016 Jun; 6():27382. PubMed ID: 27263528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor-1alpha under the control of nitric oxide.
    Brüne B; Zhou J
    Methods Enzymol; 2007; 435():463-78. PubMed ID: 17998069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
    Xia Y; Choi HK; Lee K
    Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cancer cell metabolism by hypoxia-inducible factor 1.
    Semenza GL
    Semin Cancer Biol; 2009 Feb; 19(1):12-6. PubMed ID: 19114105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normoxic expression of hypoxia-inducible factor 1 in rat Leydig cells in vivo and in vitro.
    Palladino MA; Pirlamarla PR; McNamara J; Sottas CM; Korah N; Hardy MP; Hales DB; Hermo L
    J Androl; 2011; 32(3):307-23. PubMed ID: 20966422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional up-regulation of FoxM1 in response to hypoxia is mediated by HIF-1.
    Xia LM; Huang WJ; Wang B; Liu M; Zhang Q; Yan W; Zhu Q; Luo M; Zhou ZZ; Tian DA
    J Cell Biochem; 2009 Feb; 106(2):247-56. PubMed ID: 19097132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.